Andrew Michael Intlekofer

Sloan-Kettering Inst Can Research

$5,190,407

Attributed

$5,190,407

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY2016–25

$2M$1.5M$1M$500K$0

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,190,407 · 3

By mechanism

R37$3,354,207 · 1

R01$949,520 · 1

K08$886,680 · 1

Top collaborators

No co-investigators on record.

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Ross L Levine$31,715,816
Eirini Papapetrou$13,419,805
Michael Kharas$18,485,709
Craig B Thompson$56,520,903
Aaron D Viny$3,272,036

Others in their field

Top investigators on “Enzymes”

Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
Randall J Bateman · Washington University$83,824,814
Stuart L Schreiber · Harvard University (Medical School)$49,424,554
Jay D Keasling · University Of California-Berkeley$47,558,861
David Heimbrook · Leidos Biomedical Research, Inc.$47,513,682
Susan Abushakra · Alzheon, Inc.$47,265,244

Research focus

EnzymesMutationMutantSomatic MutationProductionGene ExpressionIsocitrate DehydrogenaseMetabolicPharmaceutical PreparationsResponseAcute Myelocytic LeukemiaCellsCancer CellBiochemicalIn VitroIn VivoLeukemiaMalignant NeoplasmsTherapeutic TargetHematopoiesisBone MarrowAlpha KetoglutarateHypoxia Inducible FactorChiral Molecule